ROR1 and neoplasm: Considering the limited amount of data published on haematological indications investigating morphologically intact tumours from lymph nodes or bone marrow [9], we performed this prevalence with a well characterized anti-ROR1 clone 6D4 for IHC [7], using commercially available FFPE tissue samples.